BIOTECH 2008 – Life Sciences: A 20/20 Vision to 2020 is Burrill & Company's 22nd annual report on the state of the biotech industry, highlighting the critical developments in 2007 (across all sectors, not just human healthcare but also biofuels, agbio, industrial biotechnology, both in the US and globally). This edition has a special focus on the future and looks forward just over a decade at the projected environment for the industry in the year 2020…and develops the pathway that will lead us there. In an industry where change is a constant, Biotech 2008 is the industry’s "roadmap" and a must read for all those interested in the revolution taking place in the life sciences world…changing the way we heal the world, feed the world, and fuel the world. BIOTECH 2008 – Life Sciences: A 20/20 Vision to 2020 is available in print and digital format!

• Biotech in 2020
• 2007 Industry Financials, including 12 months of company financial data and market caps for the US, Europe, Canada, and Asia
• Analysis of key activities across industry sectors including healthcare, personalized, predictive and, preventive medicine, wellness, ag-biotech, industrial biotechnology and biofuels
• Highlights of the most important recent advances in technology including stem cells and nanotechnology
• Politics and Policy - with special features on the presidential campaign and how it is likely to affect the life sciences industry
• Analysis of deal making, the venture capital environment and capital markets
• The biotech industry around the world - Canada, Europe, Asia, with special features on emerging global players such as China, India, Malaysia, Brazil

This is a publication you don’t want to miss!

Download a sample of the BIOTECH 2008 Report

Print and Digital Copy:

$610

Biotech 2008 will be available in digital format at the end of March and in paper copy in April 2008.

*Discount does not apply to reports already purchased. The prices quoted above reflect the 10% discount.